Literature DB >> 8026741

Genotypically unbalanced diploid<==>diploid foetal mouse chimaeras: possible relevance to human confined mosaicism.

J D West1, J H Flockhart.   

Abstract

Two series of mouse chimaeras were produced by aggregating pairs of eight-cell embryos that differed at the Gpi-1s locus, encoding glucose phosphate isomerase (GPI-1); the paired embryos were respectively homozygous Gpi-1sa/Gpi-1sa and Gpi-1sb/Gpi-1sb. Chimaeric blastocysts were transferred to pseudopregnant females, that were homozygous Gpi-1sc/Gpi-1sc and produced only GPI-1C enzyme. Quantitative electrophoresis of GPI-1 was used to estimate the contribution of each embryo (GPI-1A and GPI-1B enzyme activity) to the foetus, placenta and other extraembryonic tissues of 12 1/2 day chimaeric conceptuses. For both series of chimaeras, the distributions of %GPI-1A in different tissues were classified as (1) balanced and typical, (2) balanced but atypical or (3) unbalanced. One series of chimaeras was clearly unbalanced, so that the cells derived from the (C57BL x CBA/Ca)F2 embryo (Gpi-1sb/Gpi-1sb) predominated over those derived from the BALB/c inbred strain (Gpi-1sa/Gpi-1sa) in most foetuses. Two significant observations were made concerning this unbalanced series. Firstly, the mean composition of the placenta and other extraembryonic tissues was similar to that in the foetus, i.e. also unbalanced with (C57BL x CBA/Ca)F2 (abbreviated to BF2) cells predominating. Secondly, despite this generalized deficiency of BALB/c cells, there were differences in the frequency of non-chimaeric tissues between different developmental lineages. In 20/38 [corrected] chimaeric conceptuses in the unbalanced series only BF2 cells were detected in the foetus, whereas both BF2 and BALB/c cells were present in at least one of the extraembryonic tissues. This group of chimaeras, therefore, shows some similarities to human confined mosaicism. Although chimaerism occurred more often in the primitive endoderm (hypoblast) lineage (yolk sac endoderm and parietal endoderm) than in the placenta, this may also be the case in human mosaics. The mosaic status of the human yolk sac endoderm is usually unknown so it is possible that mosaicism often occurs in the yolk sac endoderm as well as the trophectoderm in human 'confined placental mosaicism'. The uniformly unbalanced phenotype seen in the mouse chimaeras may be a result of generalized cell selection against BALB/c cells in all tissues. As an alternative explanation, we propose that most of the BALB/c cells in the blastocyst are allocated to the mural trophectoderm, which has a limited mitotic potential and so contributes little to the mid-gestation conceptus. Further work is required to test these possibilities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026741     DOI: 10.1017/s0016672300032195

Source DB:  PubMed          Journal:  Genet Res        ISSN: 0016-6723            Impact factor:   1.588


  13 in total

1.  Evaluation of the mouse TgTP6.3 tauGFP transgene as a lineage marker in chimeras.

Authors:  Gillian E MacKay; Margaret A Keighren; Linda Wilson; Thomas Pratt; Jean H Flockhart; John O Mason; David J Price; John D West
Journal:  J Anat       Date:  2005-01       Impact factor: 2.610

2.  Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye.

Authors:  J M Collinson; J C Quinn; M A Buchanan; M H Kaufman; S E Wedden; J D West; R E Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  The transcription factor Foxg1 regulates the competence of telencephalic cells to adopt subpallial fates in mice.

Authors:  Martine Manuel; Ben Martynoga; Tian Yu; John D West; John O Mason; David J Price
Journal:  Development       Date:  2010-02       Impact factor: 6.868

4.  Disruption of early events in thalamocortical tract formation in mice lacking the transcription factors Pax6 or Foxg1.

Authors:  Thomas Pratt; Jane C Quinn; T Ian Simpson; John D West; John O Mason; David J Price
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

5.  Controlled overexpression of Pax6 in vivo negatively autoregulates the Pax6 locus, causing cell-autonomous defects of late cortical progenitor proliferation with little effect on cortical arealization.

Authors:  Martine Manuel; Petrina A Georgala; Catherine B Carr; Simon Chanas; Dirk A Kleinjan; Ben Martynoga; John O Mason; Michael Molinek; Jeni Pinson; Thomas Pratt; Jane C Quinn; T Ian Simpson; David A Tyas; Veronica van Heyningen; John D West; David J Price
Journal:  Development       Date:  2007-01-03       Impact factor: 6.868

6.  The transcription factor Foxg1 regulates telencephalic progenitor proliferation cell autonomously, in part by controlling Pax6 expression levels.

Authors:  Martine N Manuel; Ben Martynoga; Mike D Molinek; Jane C Quinn; Corinne Kroemmer; John O Mason; David J Price
Journal:  Neural Dev       Date:  2011-03-18       Impact factor: 3.842

7.  Evaluation of methods for one-dimensional spatial analysis of two-dimensional patterns in mouse chimaeras.

Authors:  Benjamin A Hodson; Mathieu Unbekandt; Margaret A Keighren; Anthea Springbett; John D West
Journal:  J Anat       Date:  2011-05-27       Impact factor: 2.610

8.  Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies cortical cell identity by a cell autonomous mechanism.

Authors:  Jane C Quinn; Michael Molinek; Ben S Martynoga; Paulette A Zaki; Andrea Faedo; Alessandro Bulfone; Robert F Hevner; John D West; David J Price
Journal:  Dev Biol       Date:  2006-08-22       Impact factor: 3.582

9.  Evaluation of triploid<-->diploid and trisomy-3<-->diploid mouse chimeras as models for investigating how lineage restriction occurs in confined placental mosaicism.

Authors:  Clare A Everett; Margaret A Keighren; Jean H Flockhart; John D West
Journal:  Reproduction       Date:  2007-12       Impact factor: 3.906

10.  Effects of elevated Pax6 expression and genetic background on mouse eye development.

Authors:  Simon A Chanas; J Martin Collinson; Thaya Ramaesh; Natalie Dorà; Dirk A Kleinjan; Robert E Hill; John D West
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.